Jon A. Kyte

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial.

Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial.

Journal: Journal for immunotherapy of cancer

Published: July 08, 2026

CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade.

CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade.

Journal: Frontiers in oncology

Published: February 21, 2026

Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.

Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: June 17, 2025

Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trial.

Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 30, 2025

STEAP1: a promising target in prostate cancer therapy.

STEAP1: a promising target in prostate cancer therapy.

Journal: Trends in cancer

Published: April 18, 2025

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy.

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy.

Journal: Molecular oncology

Published: February 20, 2025

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival.

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival.

Journal: Oncoimmunology

Published: December 20, 2024

Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy.

Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy.

Journal: Immuno-oncology technology

Published: December 19, 2024

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis.

Journal: Communications medicine

Published: October 20, 2024

Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586.

Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586.

Journal: International journal of molecular sciences

Published: September 05, 2024

Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells.

Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells.

Journal: BMC research notes

Published: August 19, 2024

Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer.

Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer.

Journal: Molecular oncology

Published: May 05, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026